Nitric Oxide Signaling in Heart Failure With Preserved Ejection Fraction

There has been considerable focus on the potential role of nitric oxide (NO) and phosphodiesterase (PDE)-5 inhibition in treating heart failure with preserved ejection fraction (HFpEF). However, the results from studies have been conflicting. In a preclinical study, pre-treatment of diabetic rats wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Lucas, Ryan, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Journal Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034459/
https://www.ncbi.nlm.nih.gov/pubmed/30062153
http://dx.doi.org/10.1016/j.jacbts.2017.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034459/
https://www.ncbi.nlm.nih.gov/pubmed/30062153
http://dx.doi.org/10.1016/j.jacbts.2017.05.004

Ejemplares similares